Life360 director sells 31,275 and 18,725 shares
The Rule 10b5-1 plan adopted June 9, 2026, provides for automatic sales under predetermined criteria.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Life360, Inc. director Alex Haro exercised options for 50,000 common shares on September 21, 2026, at $2.53 per share. That day, Haro sold 31,275 shares at a weighted-average $40.72 per share and 18,725 shares at a weighted-average $41.16 per share. The transactions were effected under a Rule 10b5-1 trading plan adopted June 9, 2026. The option position covered 195,565 shares following the exercise.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (right to buy) F1, F5 | 50,000 | $0.00 | $0.00 |
| Exercise | Common stock F1, F2 | 50,000 | $2.53 | $126K |
| Sale | Common stock F1, F3, F2 | 31,275 | $40.72 | $1.27M |
| Sale | Common stock F1, F4, F2 | 18,725 | $41.16 | $771K |
Footnotes (5)
- F1. The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 9, 2026. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company.
- F2. Includes 3,342 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.
- F3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.04 to $41.02, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 3.
- F4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.047 to $41.340, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 4.
- F5. The stock option is fully vested and exercisable.
Key Figures
Key Terms
Rule 10b5-1 trading plan regulatory
weighted average price financial
restricted stock units financial
fully vested and exercisable financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What were the terms of Alex Haro's Life360 option exercise?
Were Alex Haro's Life360 sales made under a 10b5-1 plan?
AI-generated analysis. How Rhea-AI works. Not financial advice.